Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationGuidance updates on to how to notify the MHRA of changes to the PV System
The revised Schedule M prescribes the Good Manufacturing Practices (GMP) and requirements of premises, plant, and equipment for pharmaceutical products; official says this will ensure Indian guidelines are at par with global standards.
Annex 1: Manufacture of sterile medicinal products
MHRA announces two new UK Approved Bodies to certify medical devices
The European Medicines Agency (EMA) has released a major revision of its user guide for micro, small, and medium-sized enterprises (SMEs) in the pharmaceutical sector.
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-17 January 2024
An at-a-glance summary of news from around the agency.
In 2023, EMA recommended 77 medicines for marketing authorisation. Of these, 39 had a new active substance which had never been authorised in the European Union (EU) before. Among these are a number of medicines that stand out due to their contribution to address public health needs or the innovation they represent.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 January 2024
An at-a-glance summary of news from around the agency.